Brief: BioMarin Reports Third Quarter 2025 Results And Provides Corporate Update
27/10/2025 20:23
Oct 27 (Reuters) - Biomarin Pharmaceutical Inc BMRN.O: BIOMARIN REPORTS THIRD QUARTER 2025 RESULTS AND PROVIDES CORPORATE UPDATE Source text: ID:nPn1B01ZXa Further company coverage: BMRN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioMarin Pharmaceutical
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Biomarin Pharmaceutical Expects Q3 2026 Pre-Tax Charges Of $283 Million For Bought Ipr&D Expense
Brief: Biomarin Appoints Cara Bauer As Chief People Officer
Brief: Biomarin Pharmaceutical Enters Settlement And License Agreement With Ascendis Pharma On Sept 24, 2026
U.S. STOCKS ON THE MOVE-GitLab, California utilities, Herbalife